AKBA Akebia Therapeutics, Inc.

Fundamentals / CIK 0001517022 / USD

Akebia Therapeutics, Inc. reported $197.2M in revenue and a net loss of $44.56M for the trailing twelve months ended September 30, 2026 (down 37.2% year over year), with a 78.9% gross margin and a -15.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AKBA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$370.7M$185.3M$0-$387.0MFY 2016 Revenue: $1.53MFY 2016 Net Income: -$135.7M2016FY 2017 Revenue: $181.2MFY 2017 Net Income: -$73.67M2017FY 2018 Revenue: $207.7MFY 2018 Net Income: -$143.6M2018FY 2019 Revenue: $335.0MFY 2019 Net Income: -$279.7M2019FY 2020 Revenue: $295.3MFY 2020 Net Income: -$383.5M2020FY 2021 Revenue: $213.6MFY 2021 Net Income: -$282.0M2021FY 2022 Revenue: $292.5MFY 2022 Net Income: -$94.23M2022FY 2023 Revenue: $194.6MFY 2023 Net Income: -$51.92M2023FY 2024 Revenue: $160.2MFY 2024 Net Income: -$69.41M2024FY 2025 Revenue: $236.2MFY 2025 Net Income: -$5.34M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $236.2M $160.2M $194.6M $292.5M $213.6M $295.3M $335.0M $207.7M $181.2M $1.53M
Cost of Revenue $39.46M $63.18M $74.15M $85.57M $153.4M $295.9M $145.3M $7.77M -- --
Gross Profit $196.7M $97.00M $120.5M $206.9M $60.18M -$601K $189.7M $200.0M -- --
Research & Development $62.36M $37.65M $63.08M $130.0M $147.9M $218.5M $323.0M $291.0M $230.9M $115.8M
Selling, General & Admin $107.5M $106.5M $100.2M $138.6M $174.2M $153.9M $149.5M $87.06M $27.01M $22.21M
Total Operating Expenses $173.2M $147.5M $166.7M $287.7M $325.5M $375.8M $476.0M $378.1M $257.9M $138.0M
Operating Income $23.50M -$50.47M -$46.26M -$80.78M -$265.3M -$376.4M -$286.3M -$178.2M -$76.67M -$136.5M
EBITDA $24.77M -$12.97M -$8.63M -$79.12M -$263.4M -$374.4M -$284.0M -$177.3M -$76.06M -$136.2M
Interest Income -- -- -- -- -- -- -- -- -- $901K
Income Before Tax -$3.72M -$69.41M -$51.92M -$94.23M -$282.8M -$383.5M -$286.3M -$171.9M -$73.67M -$135.7M
Income Tax Expense $1.62M $0 $0 $0 $0 $0 -$6.63M -$28.34M -- --
Net Income -$5.34M -$69.41M -$51.92M -$94.23M -$282.0M -$383.5M -$279.7M -$143.6M -$73.67M -$135.7M
Basic EPS -$0.02 -$0.33 -$0.28 -$0.52 -$1.70 -$2.77 -$2.36 -$2.47 -$1.69 -$3.60
Diluted EPS -$0.02 -$0.33 -$0.28 -$0.52 -$1.70 -$2.77 -$2.36 -$2.47 -$1.69 -$3.60
Basic Shares Outstanding 257.2M 210.9M 187.5M 182.8M 165.9M 138.5M 118.4M 58.0M 43.5M 37.7M
Diluted Shares Outstanding 257.2M 210.9M 187.5M 182.8M 165.9M 138.5M 118.4M 58.0M 43.5M 37.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $36.90M $49.13M $53.54M $57.62M $58.77M $62.47M $57.34M $46.50M
Cost of Revenue $6.36M $10.42M $12.29M $12.54M $9.38M $9.92M $7.62M $20.36M
Gross Profit $30.54M $38.70M $41.25M $45.09M $49.38M $52.55M $49.71M $26.13M
Research & Development $16.18M $14.06M $14.81M $26.65M $14.94M $11.01M $9.75M $11.79M
Selling, General & Admin $23.53M $28.17M $30.44M $26.09M $29.09M $26.55M $25.74M $27.68M
Total Operating Expenses $42.00M $45.03M $45.95M $53.64M $44.93M $38.46M $36.20M $40.44M
Operating Income -$11.46M -$6.33M -$4.70M -$8.55M $4.45M $14.09M $13.51M -$14.31M
EBITDA -$11.36M -$5.74M -$4.37M -$8.23M $4.77M $14.40M $13.83M -$4.96M
Income Before Tax -$14.18M -$8.84M -$8.93M -$11.23M $1.16M $247K $6.11M -$22.80M
Income Tax Expense $175K $70K $126K $1.01M $615K $0 $0 --
Net Income -$14.35M -$8.91M -$9.05M -$12.24M $540K $247K $6.11M -$22.80M
Basic EPS -$0.05 -$0.03 -$0.03 -- $0.00 $0.00 $0.03 --
Diluted EPS -$0.05 -$0.03 -$0.03 -- $0.00 $0.00 $0.03 --
Basic Shares Outstanding 276.9M 269.6M 267.0M -- 264.8M 262.6M 235.5M --
Diluted Shares Outstanding 276.9M 269.6M 267.0M -- 274.4M 271.1M 241.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $184.8M $51.87M $42.92M $90.47M $149.8M $228.7M $147.4M $104.6M $70.16M $187.3M
Short-Term Investments -- -- -- -- -- -- $245K $216.8M $217.9M $65.07M
Cash & Short-Term Investments $184.8M $51.87M $42.92M $90.47M $149.8M $268.7M $147.7M $321.6M $317.8M $260.3M
Accounts Receivable, Net $47.03M $34.37M $39.29M $40.28M $50.88M $26.85M $38.86M $16.67M $34.22M $33.82M
Inventory $15.61M $16.24M $15.69M $21.57M $38.20M $61.02M $116.3M $114.2M -- --
Other Current Assets $3.77M $7.32M $5.75M $17.25M -- -- -- -- -- --
Total Current Assets $253.0M $113.8M $118.1M $185.2M $272.0M $371.4M $309.5M $468.3M $358.4M $296.3M
Property, Plant & Equipment, Net $1.22M $2.20M $3.63M $5.21M $6.75M $8.62M $10.38M $8.02M $3.62M $2.61M
Goodwill $59.04M $59.04M $59.04M $59.04M $55.05M $55.05M $55.05M $55.05M -- --
Intangible Assets -- $0 $36.04M $72.08M $108.1M $144.2M $291.2M $328.2M -- --
Long-Term Investments -- -- -- -- -- -- -- $245K $29.75M $7.94M
Other Non-Current Assets $59.68M $37.38M $12.42M $5.37M $49.75M $37.98M $75.98M $137.0M $2.27M $1.28M
Total Non-Current Assets $123.6M $106.8M $123.6M $170.9M $253.5M $272.7M $461.7M $528.3M $5.89M $3.90M
Total Assets $376.6M $220.7M $241.7M $356.1M $525.5M $644.1M $771.2M $996.5M $364.2M $300.2M
Accounts Payable $21.18M $15.18M $14.63M $18.02M $33.59M $41.31M $39.22M $42.80M $7.00M $2.04M
Short-Term Debt $0 $0 $17.50M $32.00M $97.54M $0 -- $15.00M -- --
Deferred Revenue (Current) $2.68M $0 $0 $3.74M $20.91M $15.21M $39.83M $56.98M $81.67M $81.97M
Total Current Liabilities $162.9M $80.91M $99.87M $129.5M $256.5M $187.1M $208.1M $265.7M $141.1M $114.3M
Long-Term Debt $48.25M $38.69M $17.18M $34.08M $0 $96.38M $75.81M -- -- --
Deferred Revenue (Non-Current) -- $0 $43.30M $43.30M $21.47M $25.34M $33.12M $55.71M $97.96M $115.3M
Other Non-Current Liabilities $1.82M $4.75M $8.88M $15.72M $82.53M $60.61M $30.22M $29.57M $22K $27K
Total Non-Current Liabilities $181.0M $188.9M $172.4M $221.3M $192.6M $209.4M $168.3M $94.92M $100.6M $117.8M
Total Liabilities $344.0M $269.9M $272.3M $350.8M $449.1M $396.5M $376.4M $360.6M $241.7M $232.1M
Total Debt (incl. Leases) $51.80M $47.64M $48.12M $99.78M $136.4M $126.3M $108.3M $15.00M -- --
Common Stock $2.0K $2.0K $2.0K $2.0K $1.0K $1.0K $1.0K $1.0K $0 $0
Retained Earnings -$1.68B -$1.68B -$1.61B -$1.56B -$1.46B -$1.18B -$794.1M -$514.4M -$370.8M -$297.1M
Accumulated Other Comp. Income $6.0K $6.0K $6.0K $6.0K $6.0K $13K $0 -$261K -$442K -$42K
Total Stockholders' Equity $32.61M -$49.19M -$30.58M $5.23M $74.01M $247.6M $394.8M $635.9M $122.6M $68.12M
Total Equity $32.61M -$49.19M -$30.58M $5.23M $74.01M $247.6M $394.8M $635.9M $122.6M $68.12M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $159.3M $155.5M $162.6M $184.8M $166.4M $137.3M $113.4M $51.87M
Cash & Short-Term Investments $159.3M $155.5M $162.6M $184.8M $166.4M $137.3M $113.4M $51.87M
Accounts Receivable, Net $36.44M $53.51M $62.54M $47.03M $66.22M $72.81M $61.54M $34.37M
Inventory $18.70M $13.02M $13.00M $15.61M $18.64M $16.71M $19.73M $16.24M
Other Current Assets $6.39M $5.77M $3.60M $3.77M $5.33M $7.83M $7.92M $7.32M
Total Current Assets $220.8M $229.6M $243.5M $253.0M $258.3M $234.7M $203.8M $113.8M
Property, Plant & Equipment, Net $2.40M $1.51M $956K $1.22M $1.47M $1.71M $1.90M $2.20M
Goodwill $59.04M $59.04M $59.04M $59.04M $59.04M $59.04M $59.04M $59.04M
Intangible Assets -- -- -- -- -- -- -- $0
Other Non-Current Assets $50.22M $53.75M $56.57M $59.68M $40.46M $44.19M $38.34M $37.38M
Total Non-Current Assets $121.3M $120.1M $119.0M $123.6M $105.8M $110.9M $106.4M $106.8M
Total Assets $342.1M $349.7M $362.5M $376.6M $364.2M $345.6M $310.2M $220.7M
Accounts Payable $7.61M $9.42M $8.39M $21.18M $10.09M $11.55M $12.66M $15.18M
Short-Term Debt $37.49M $24.81M $12.49M $0 -- -- -- $0
Deferred Revenue (Current) $4.96M $6.17M $4.50M $2.68M $3.88M $5.53M $1.24M $0
Total Current Liabilities $162.3M $160.9M $173.9M $162.9M $133.4M $118.7M $91.23M $80.91M
Long-Term Debt $12.78M $24.75M $36.40M $48.25M $47.64M $47.06M $46.51M $38.69M
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $0
Other Non-Current Liabilities $897K $562K $681K $1.82M $5.00M $5.36M $5.11M $4.75M
Total Non-Current Liabilities $159.4M $163.8M $161.3M $181.0M $189.2M $197.7M $194.4M $188.9M
Total Liabilities $321.8M $324.6M $335.1M $344.0M $322.6M $316.4M $285.6M $269.9M
Total Debt (incl. Leases) $60.49M $54.90M $51.02M $51.80M $52.58M $53.36M $54.15M $47.64M
Common Stock $3.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K $2.0K
Retained Earnings -$1.72B -$1.70B -$1.69B -$1.68B -$1.67B -$1.67B -$1.67B -$1.68B
Accumulated Other Comp. Income $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K
Total Stockholders' Equity $20.37M $25.02M $27.38M $32.61M $41.59M $29.22M $24.58M -$49.19M
Total Equity $20.37M $25.02M $27.38M $32.61M $41.59M $29.22M $24.58M -$49.19M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$5.34M -$69.41M -$51.92M -$92.56M -$282.8M -$383.5M -$279.7M -$143.6M -$73.67M -$135.7M
Depreciation & Amortization $1.27M $37.50M $37.63M $1.65M $1.93M $2.08M $2.25M $899K $617K $296K
Stock-Based Compensation $11.28M $7.78M $9.32M $17.85M $22.73M $24.46M $11.93M $19.04M $8.87M $5.83M
Change in Receivables -$14.14M $4.05M $994K $11.30M -$24.02M $12.01M -$22.20M $33.38M -$393K -$33.82M
Change in Inventory -$23.12M -$28.40M -$2.54M $19.09M -$25.85M $6.16M -$29.14M $26K -- --
Change in Payables $3.08M -$1.36M -$5.24M $1.50M -$11.73M $3.68M $1.37M $13.72M $4.96M -$274K
Operating Cash Flow $67.99M -$40.66M -$23.38M -$73.15M -$253.0M -$110.4M -$257.4M -$97.49M -$56.16M $57.91M
Capital Expenditure -$291K -$33K $0 -$114K -$59K -$317K -$6.66M -$1.61M -$1.62M -$2.66M
Free Cash Flow $67.70M -$40.69M -$23.38M -$73.27M -$253.0M -$110.7M -$264.1M -$99.10M -$57.78M $55.24M
Purchases of Investments -- -- -- $0 $0 -$99.93M $0 -$224.2M -$330.6M -$147.0M
Sales & Maturities of Investments -- -- -- -- $40.00M $60.24M $217.8M $256.3M $155.0M --
Investing Cash Flow -$7.93M -$33K $0 -$114K $39.94M -$40.00M $211.2M $36.59M -$177.3M $12.71M
Common Stock Issued -- -- -- -- -- -- -- -- $373.1M --
Financing Cash Flow $72.93M $49.66M -$25.21M $14.60M $133.7M $231.7M $88.97M $96.56M $116.2M $66.95M
Net Change in Cash $133.0M $8.97M -$48.59M -$58.67M -$79.29M $81.33M $42.70M $35.66M -$117.2M $137.6M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$14.35M -$8.91M -$9.05M -$12.24M $540K $247K $6.11M -$22.80M
Depreciation & Amortization $101K $585K $328K $321K $318K $316K $314K $9.35M
Stock-Based Compensation $2.80M $3.23M $3.67M $3.20M $3.22M $2.68M $2.19M $1.70M
Change in Receivables $16.97M $9.03M -$15.70M $19.10M $6.16M -$11.53M -$27.87M -$3.07M
Change in Inventory -$1.65M -$655K -$2.54M -$17.42M $6.90M -$7.65M -$4.95M -$8.50M
Change in Payables -$2.58M $2.60M -$7.79M $10.42M -$8.83M $3.73M -$2.23M $2.39M
Operating Cash Flow $2.33M $3.52M -$21.21M $31.13M $28.11M $22.34M -$13.59M -$4.47M
Capital Expenditure -$706K -$1.08M -$62K -$70K -$77K -$126K -$18K -$2.0K
Free Cash Flow $1.63M $2.45M -$21.27M $31.06M $28.03M $22.22M -$13.61M -$4.47M
Investing Cash Flow -$2.61M -$4.08M -$62K -$7.88M -$77K -$126K $154K -$2.0K
Financing Cash Flow $3.18M -$6.54M -$926K -$4.85M $1.11M $1.72M $74.94M $22.32M
Net Change in Cash $2.90M -$7.09M -$22.20M $18.40M $29.14M $23.94M $61.51M $17.86M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 83.3% 60.6% 61.9% 70.7% 28.2% -0.2% 56.6% 96.3% -- --
Operating Margin 9.9% -31.5% -23.8% -27.6% -124.2% -127.5% -85.5% -85.8% -42.3% -8889.9%
Net Profit Margin -2.3% -43.3% -26.7% -32.2% -132.0% -129.9% -83.5% -69.1% -40.7% -8843.5%
Return on Equity (ROE) -16.4% -- -- -1801.6% -381.1% -154.9% -70.8% -22.6% -60.1% -199.3%
Return on Assets (ROA) -1.4% -31.5% -21.5% -26.5% -53.7% -59.5% -36.3% -14.4% -20.2% -45.2%
Current Ratio 1.55x 1.41x 1.18x 1.43x 1.06x 1.98x 1.49x 1.76x 2.54x 2.59x
Quick Ratio 1.46x 1.21x 1.03x 1.26x 0.91x 1.66x 0.93x 1.33x 2.49x 2.57x
Debt to Equity 1.59x -- -- 19.08x 1.84x 0.51x 0.27x 0.02x -- --
Revenue Growth (YoY) +47.5% -17.7% -33.5% +36.9% -27.7% -11.8% +61.3% +14.6% +11706.3% --
Gross Profit Growth (YoY) +102.8% -19.5% -41.8% +243.8% -- -100.3% -5.2% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -197.0% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -204.6% --
5Y Revenue / Share Growth -56.9% -73.2% -71.0% -61.6% +3062.3% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 78.9% 79.6% 81.0% 83.3% 79.0% 74.4% 68.0% 60.6%
Operating Margin -15.7% -6.9% 2.3% 9.9% 7.9% 0.4% -11.9% -31.5%
Net Profit Margin -22.6% -13.5% -8.8% -2.3% -7.1% -17.9% -24.5% -43.3%
Return on Equity (ROE) -218.8% -118.6% -74.9% -16.4% -38.2% -124.8% -184.3% --
Return on Assets (ROA) -13.0% -8.5% -5.7% -1.4% -4.4% -10.6% -14.6% -31.5%
Current Ratio 1.36x 1.43x 1.40x 1.55x 1.94x 1.98x 2.23x 1.41x
Quick Ratio 1.24x 1.35x 1.33x 1.46x 1.80x 1.84x 2.02x 1.21x
Debt to Equity 2.97x 2.19x 1.86x 1.59x 1.26x 1.83x 2.20x --
Revenue Growth (YoY) -37.2% -21.4% -6.6% +23.9% +57.0% +43.1% +75.8% -17.3%
Gross Profit Growth (YoY) -38.2% -26.4% -17.0% +72.5% +112.2% +97.6% +136.7% -30.4%
Operating Income Growth (YoY) -357.6% -144.9% -134.7% -- -- -- -- -1141.3%
Net Income Growth (YoY) -2758.1% -3706.5% -248.1% -- -- -- -- -3814.0%
EPS Growth (YoY) -- -- -200.0% -- -- -- -- --
Operating Cash Flow Growth (YoY) -91.7% -84.2% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -94.2% -89.0% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001517022) · from December 31, 2012 Data through September 30, 2026 · synced Nov 20, 2026, 05:46 UTC · Open in terminal